MD4407C1 - Ингибитор клеток HL-60 миелоидной лейкемии человека на основе гидрата хлорида бис[N-(проп-2-ен-1-ил)-2-(пиридин-2-илметилиден)-гидразинкарботиоамид]-никеля(II) - Google Patents
Ингибитор клеток HL-60 миелоидной лейкемии человека на основе гидрата хлорида бис[N-(проп-2-ен-1-ил)-2-(пиридин-2-илметилиден)-гидразинкарботиоамид]-никеля(II) Download PDFInfo
- Publication number
- MD4407C1 MD4407C1 MDA20150041A MD20150041A MD4407C1 MD 4407 C1 MD4407 C1 MD 4407C1 MD A20150041 A MDA20150041 A MD A20150041A MD 20150041 A MD20150041 A MD 20150041A MD 4407 C1 MD4407 C1 MD 4407C1
- Authority
- MD
- Moldova
- Prior art keywords
- nickel
- ylmethylidene
- prop
- bis
- hydrazinecarbothioamide
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title claims abstract description 8
- 208000025113 myeloid leukemia Diseases 0.000 title claims description 12
- HGGYAQHDNDUIIQ-UHFFFAOYSA-L dichloronickel;hydrate Chemical compound O.Cl[Ni]Cl HGGYAQHDNDUIIQ-UHFFFAOYSA-L 0.000 title claims description 7
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 title description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 abstract description 4
- 208000032839 leukemia Diseases 0.000 abstract description 3
- 229910052723 transition metal Inorganic materials 0.000 abstract description 3
- 150000003624 transition metals Chemical class 0.000 abstract description 3
- 238000011282 treatment Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- 238000011321 prophylaxis Methods 0.000 abstract description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- -1 pyridin-2-ylmethylidene Chemical group 0.000 abstract 1
- FGHSTPNOXKDLKU-UHFFFAOYSA-N nitric acid;hydrate Chemical compound O.O[N+]([O-])=O FGHSTPNOXKDLKU-UHFFFAOYSA-N 0.000 description 6
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 5
- VEQPNABPJHWNSG-UHFFFAOYSA-N Nickel(2+) Chemical compound [Ni+2] VEQPNABPJHWNSG-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- HGUDBTHYULAESG-UHFFFAOYSA-N 1-prop-2-enyl-3-(pyridin-2-ylmethylideneamino)thiourea Chemical compound C=CCNC(=S)NN=CC1=CC=CC=N1 HGUDBTHYULAESG-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 description 1
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003327 cancerostatic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000006263 metalation reaction Methods 0.000 description 1
- 150000002815 nickel Chemical group 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к химии, а именно к координационному соединению класса тиосемикарбазонатов переходных металлов и может найти применение в медицине для профилактики и лечения миелоидной лейкемии человека.Сущность изобретения заключается в том, что в качестве ингибитора клеток HL-60 миелоидной лейкемии человека предлагается новое соединение гидрат хлорида бис[N-(проп-2-ен-1-ил)-2-(пиридин-2-илметилиден)гидразинкарботиоамид]никеля(II) формулы :Заявляемое соединение расширяет спектр высокоактивных ингибиторов клеток миелоидной лейкемии человека.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20150041A MD4407C1 (ru) | 2015-04-29 | 2015-04-29 | Ингибитор клеток HL-60 миелоидной лейкемии человека на основе гидрата хлорида бис[N-(проп-2-ен-1-ил)-2-(пиридин-2-илметилиден)-гидразинкарботиоамид]-никеля(II) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20150041A MD4407C1 (ru) | 2015-04-29 | 2015-04-29 | Ингибитор клеток HL-60 миелоидной лейкемии человека на основе гидрата хлорида бис[N-(проп-2-ен-1-ил)-2-(пиридин-2-илметилиден)-гидразинкарботиоамид]-никеля(II) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD4407B1 MD4407B1 (ru) | 2016-03-31 |
| MD4407C1 true MD4407C1 (ru) | 2016-10-31 |
Family
ID=55646048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20150041A MD4407C1 (ru) | 2015-04-29 | 2015-04-29 | Ингибитор клеток HL-60 миелоидной лейкемии человека на основе гидрата хлорида бис[N-(проп-2-ен-1-ил)-2-(пиридин-2-илметилиден)-гидразинкарботиоамид]-никеля(II) |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD4407C1 (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4434C1 (ru) * | 2015-10-09 | 2017-04-30 | Государственный Университет Молд0 | Использование N'-[1-(2-пиридил)этилиден]морфолин-4-карботиогидразида в качестве ингибитора пролиферации клеток HL-60 миелоидной лейкемии человека |
| MD4520C1 (ru) * | 2016-12-16 | 2018-05-31 | Государственный Университет Молд0 | N-(4-бутоксифенил)-2-(пиридин-2-илметилиден)гидразинкарботиоамид в качестве ингибитора роста клеток T-47D рака молочной железы |
Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1448295A (en) * | 1974-05-01 | 1976-09-02 | Farmaceutici Italia | Thiosemicarbazones |
| WO1985000955A1 (en) * | 1983-08-22 | 1985-03-14 | A/S Cheminova | A biocidal, particularly fungicidal and/or bactericidal composition and thiosemicarbazones and metal complexes thereof for use in the composition |
| US4657903A (en) * | 1982-03-31 | 1987-04-14 | The United States Of America As Represented By The Secretary Of The Army | Transition metal complexes of the selenium analogs of 2-acetyl- and 2-propionylpyridine thiosemicarbazones useful for treating malarial infections and leukemia |
| US5281715A (en) * | 1992-05-13 | 1994-01-25 | Yale University | 2-formylpyridine thiosemicarbazone compounds |
| WO2004069801A1 (en) * | 2003-02-05 | 2004-08-19 | Unisearch Limited | Metal ion chelators and therapeutic use thereof |
| MD3098G2 (ru) * | 2006-01-03 | 2007-02-28 | Государственный Университет Молд0 | Дигидрат ди(?-Офенокси)-ди[N-(2-окси-1-бензаль)-N1-?-оксифуральгидразино(2-)меди] со свойствами ингибитора миелоидной лейкемии человека |
| MD3655G2 (ru) * | 2007-09-03 | 2009-02-28 | Государственный Университет Молд0 | Ингибитор миелоидной лейкемии человека на основе бис(2-гидрокси-8-фенил-трицикло/7.3.1.0.2,7/-тридекан-13-он-тиосемикарбазонато)меди |
| MD3890F1 (en) * | 2008-09-08 | 2009-04-30 | Universitatea De Stat Din Moldova | Inhibitors of human myeloid leukemia on base of coordinative compounds of copper(II) with salicylidene thiocarbazides |
| MD20110040A1 (ru) * | 2011-05-10 | 2012-11-30 | Государственный Университет Молд0 | Ингибиторы миелоидной лейкемии человека на основе 2-[2-(пиридин-2-илметилиден)гидразино]-1,3-бензотиазола и 2-[2-(1-пиридин-2-илэтилиден)-гидразино]-1,3-бензотиазол дигидрата |
| MD4190C1 (ru) * | 2011-06-16 | 2013-07-31 | Государственный Университет Молд0 | Ингибитор миелоидной лейкемии человека на основе {бис[2-(3,5-дибром-2-гидроксифенил)-2-оксоэтил-пиперидин-1-карбодитиоато(1-)-O,O']меди} |
| MD4215C1 (ru) * | 2012-07-09 | 2013-11-30 | Государственный Университет Молд0 | Ингибитор миелоидой лейкемии человека на основе N-(4-(5-( пиридин-2-ил)-4,5-дигидро-1Н-пиразол-3-ил)фенил)-2-(пиридин-2-илметилен)-гидразинкарботиоамида |
| CN103951602A (zh) * | 2014-03-19 | 2014-07-30 | 河南理工大学 | 具有抗肿瘤活性的吡咯缩氨基硫脲铜、镍配合物的合成方法 |
| MD4300B1 (ru) * | 2012-12-28 | 2014-08-31 | Universitatea De Stat Din Moldova | Ингибитора роста клеток HepG2 при раке печени на основе хлоро-¢2-фенил(пиридин-2-ил)метанон-4-(3-метоксифенил)тиосемикарбазоно]никеля |
-
2015
- 2015-04-29 MD MDA20150041A patent/MD4407C1/ru not_active IP Right Cessation
Patent Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1448295A (en) * | 1974-05-01 | 1976-09-02 | Farmaceutici Italia | Thiosemicarbazones |
| US4657903A (en) * | 1982-03-31 | 1987-04-14 | The United States Of America As Represented By The Secretary Of The Army | Transition metal complexes of the selenium analogs of 2-acetyl- and 2-propionylpyridine thiosemicarbazones useful for treating malarial infections and leukemia |
| WO1985000955A1 (en) * | 1983-08-22 | 1985-03-14 | A/S Cheminova | A biocidal, particularly fungicidal and/or bactericidal composition and thiosemicarbazones and metal complexes thereof for use in the composition |
| US5281715A (en) * | 1992-05-13 | 1994-01-25 | Yale University | 2-formylpyridine thiosemicarbazone compounds |
| US5721259A (en) * | 1992-05-13 | 1998-02-24 | Yale University | Method of using 2-formylpyridine thiosemicarbazone compounds |
| WO2004069801A1 (en) * | 2003-02-05 | 2004-08-19 | Unisearch Limited | Metal ion chelators and therapeutic use thereof |
| MD3098G2 (ru) * | 2006-01-03 | 2007-02-28 | Государственный Университет Молд0 | Дигидрат ди(?-Офенокси)-ди[N-(2-окси-1-бензаль)-N1-?-оксифуральгидразино(2-)меди] со свойствами ингибитора миелоидной лейкемии человека |
| MD3655G2 (ru) * | 2007-09-03 | 2009-02-28 | Государственный Университет Молд0 | Ингибитор миелоидной лейкемии человека на основе бис(2-гидрокси-8-фенил-трицикло/7.3.1.0.2,7/-тридекан-13-он-тиосемикарбазонато)меди |
| MD3890F1 (en) * | 2008-09-08 | 2009-04-30 | Universitatea De Stat Din Moldova | Inhibitors of human myeloid leukemia on base of coordinative compounds of copper(II) with salicylidene thiocarbazides |
| MD20110040A1 (ru) * | 2011-05-10 | 2012-11-30 | Государственный Университет Молд0 | Ингибиторы миелоидной лейкемии человека на основе 2-[2-(пиридин-2-илметилиден)гидразино]-1,3-бензотиазола и 2-[2-(1-пиридин-2-илэтилиден)-гидразино]-1,3-бензотиазол дигидрата |
| MD4190C1 (ru) * | 2011-06-16 | 2013-07-31 | Государственный Университет Молд0 | Ингибитор миелоидной лейкемии человека на основе {бис[2-(3,5-дибром-2-гидроксифенил)-2-оксоэтил-пиперидин-1-карбодитиоато(1-)-O,O']меди} |
| MD4215C1 (ru) * | 2012-07-09 | 2013-11-30 | Государственный Университет Молд0 | Ингибитор миелоидой лейкемии человека на основе N-(4-(5-( пиридин-2-ил)-4,5-дигидро-1Н-пиразол-3-ил)фенил)-2-(пиридин-2-илметилен)-гидразинкарботиоамида |
| MD4300B1 (ru) * | 2012-12-28 | 2014-08-31 | Universitatea De Stat Din Moldova | Ингибитора роста клеток HepG2 при раке печени на основе хлоро-¢2-фенил(пиридин-2-ил)метанон-4-(3-метоксифенил)тиосемикарбазоно]никеля |
| CN103951602A (zh) * | 2014-03-19 | 2014-07-30 | 河南理工大学 | 具有抗肿瘤活性的吡咯缩氨基硫脲铜、镍配合物的合成方法 |
Non-Patent Citations (10)
| Title |
|---|
| Belkis Atasever et al. Cytotoxic activities of new iron(III) and nickel(II) chelates of some S-methyl-thiosemicarbazones on K562 and ECV304 cells. Publicat online 2010. Accesat în Internet la 2015.12.10, url: http://research.sabanciuniv.edu/14005/2/belkis-OK.pdf Fig. 1 and Table 1. * |
| Chumakov, Yu. M.; Tsapkov, V.I.; Jeanneau, E.; Bairac,N.N,; Bocelli, G.; Poirier, D.; Roy, J.; Gulea, A.P. Crystal structures of copper(II) chloride, copper(II) nitrate complexes with pyridine-2-carbaldehyde thiosemicarbazone. Crystallography Reports, Vol. 53, Issue 5, pp. 786-792. Regăsit în Internet la 2015.12.12, url: http://link.springer.com/article/10.1134%2FS1063774508050106#page-1 DOI: 10.1134/S1063774508050106 Abstract * |
| Elena Pahontu et al. Antibacterial, antifungal and in vitro antileukemia activity of metal complexes with thiosemicarbazones. J. Cell. Mol. Med. Vol. 19, No 4, 2015 pp. 865-878 (First published online 24 FEB 2015). Regăsit în Internet la 2015.12.10, url: http://onlinelibrary.wiley.com/doi/10.1111/jcmm.12508/abstract pag. 869, Table 2, compound (6) * |
| Giorgio Pelosi. Thiosemicarbazone Metal Complexes: From Structure to Activity. The Open Crystallography Journal, 2010, 3, 16-28. Ultima accesare la 2015.11.30, url: http://benthamopen.com/contents/pdf/TOCRYJ/TOCRYJ-3-16.pdf Chapter 2.1 Antitumor activity * |
| K.A. Jensen et al. Studies of Thioacides and Their Derivatives IX. Thiosemicarbazides. Acta Chemica Scandinavica, 22 (1968), 1-50. Accesat prin Internet la 2015.12.07, url: http://actachemscand.org/pdf/acta_vol_22_p0001-0050.pdf pag. 2, Table 1, see 4-Allyl; pag. 49, ref. 60. * |
| Marta Sobiesiak et al. Co(II), Ni(II) and Cu(II) complexes with phenylthiazole and thiosemicarbazone-derived ligands: synthesis, structure and cytotoxic effects. New J. Chem., 2014, 38, 5349-5361. DOI: 10.1039/C4NJ00977K Regăsit în Internet la 2015.12.08, url: http://pubs.rsc.org/en/content/articlelanding/2014/nj/c4nj00977k#!divAbstract Abstract and figure * |
| Tripathi Laxmi et al. Review article. Role of chelates in treatment of cancer. Indian Journal of Cancer, April-June 2007, vol. 44, issue 2, pag. 65, Table 1, Miscellaneous; pag. 68 Miscellaneous chelates (regăsit in Internet la 2015.12.07, url: http://www.bioline.org.br/pdf?cn07011 ) articolul integral * |
| V. Graur, E. Zariciuc, V. Tsapkov, A. Gulea. SYNTHESIS AND BIOLOGICAL ACTIVITY OF NICKEL AND COPPER COORDINATION COMPOUNDS OF 5-NITROFURAN-2-CARBALDEHYDE N(4)-ALLYL-3-THIOSEMICARBAZONE. STUDIA UNIVERSITATIS MOLDAVIAE, 2014, nr.6(76). Seria "Stiinte reale si ale naturii", p.119--123 ISSN online 1857-498X (disponibil on-line 2014.12.23). Regăsit în Internet la 2015.12.08, url: http://studiamsu.eu/wp-content/uploads/19.-p.119-123-Chimie.pdf articol integral * |
| V. Graur, S. Savcin, V. Tsapkov, A Gulea. SYNTHESIS AND TUMOR ACTIVITY OF COPPER, NICKEL AND COBALT COORDINATION COMPOUNDS WITH 1-(2-HYDROXYPHENYL)ETHANONE N(4)-ALLYL-3-THIOSEMICARBAZONE. STUDIA UNIVERSITATIS MOLDAVIAE, 2015, nr.1(81). Seria "Stiinte reale si ale naturii", p.210--215 ISSN online 1857-498X (disponibil online 2015.08.22). Regăsit în Internet la 2015.12.08, url: http://oaji.net/articles/2015/2052-1438271355.pdf artiicolul integral * |
| Yasemin d. Kurt et al. Iron(III) and nickel(II) template complexes derived from benzophenone thiosemicarbazones. J. Coord. Chem. 62 (13), 2009, p. 2172-2181. Published online 01 Jun 2009. DOI: 10.1080/00958970902787775 Rezumat regăsit în Internet la 2015.12.10, url: http://www.tandfonline.com/doi/abs/10.1080/00958970902787775?journalCode=gcoo20 Documentul integral * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD4407B1 (ru) | 2016-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saeed et al. | Synthesis, characterization and antibacterial activity of nickel (II) and copper (II) complexes of N-(alkyl (aryl) carbamothioyl)-4-nitrobenzamide | |
| Vafazadeh et al. | Synthesis and structural studies of mono-and dinuclear Cu (II) complexes with an ONO donor Schiff base ligand: Self-assembly and sulfato-bridged | |
| Dong et al. | Synthesis, crystal structure and spectral properties of a supramolecular trinuclear nickel (II) complex with 5-methoxy-4′-bromo-2, 2′-[ethylenedioxybis (nitrilomethylidyne)] diphenol | |
| Khan et al. | Synthesis, structural characterization and biological screening of heteroleptic palladium (II) complexes | |
| El-Sayed et al. | Spectroscopic characterization and biological activity of dihydrazone transition metal complexes: Crystal structure of 2, 3-butanedione bis (isonicotinylhydrazone) | |
| Sroor et al. | Five different types of η 8-cyclooctatetraenyl-lanthanide half-sandwich complexes from one ligand set, including a “giant neodymium wheel” | |
| MD4407C1 (ru) | Ингибитор клеток HL-60 миелоидной лейкемии человека на основе гидрата хлорида бис[N-(проп-2-ен-1-ил)-2-(пиридин-2-илметилиден)-гидразинкарботиоамид]-никеля(II) | |
| Tauchman et al. | Cationic triruthenium (III) oxo complexes of the type [Ru3O (OAc) 6L3]+ containing imidazole, pyrazole, thiazole and oxazole ligands: Synthesis, molecular structure, and cytotoxicity | |
| MD4132C1 (ru) | Ди(µ-S)-бис{хлоро-[фенил(пиридин-2-ил)метанон-тиосемикарбазонато(1-)]медь} проявляющий свойство ингибитора пролиферации клеток T-47D рака молочной железы | |
| Zhang et al. | Syntheses, crystal structures and antimicrobial activities of thioether ligands containing quinoline and pyridine terminal groups and their transition metal complexes | |
| Roy et al. | Syntheses, electrolytic behaviour and antifungal activities of Zn (II) complexes of isomers of 3, 10-C-meso-3, 5, 7, 7, 10, 12, 14, 14-octamethyl-1, 4, 8, 11-tetraazacyclotetradecane (L). Crystal and molecular structure of [ZnLB (NO3)] NO3 (LB= a, e, a, eL) | |
| MD4393C1 (ru) | Ингибитор клеток HL-60 миелоидной лейкемии человека на основе нитрато-[N′-(1-пиридин-2-илметилиден)морфолин-4-карботиогидразидо(1-)]меди | |
| MD4190C1 (ru) | Ингибитор миелоидной лейкемии человека на основе {бис[2-(3,5-дибром-2-гидроксифенил)-2-оксоэтил-пиперидин-1-карбодитиоато(1-)-O,O']меди} | |
| Lee et al. | Pd–Ln and Pt–Ln complexes of a bi-compartmental ligand:[MLn (L)(NO3) 3](M= Pd, Pt; Ln= Eu, Tb; H2L= N, N′-bis (3-methoxysalicylidenimino-1, 3-diaminopropane)) | |
| Gusev et al. | Copper (II) complexes with flexible polydentate bispicolylamidrazone ligands: Synthesis, structure and magnetic studies | |
| BOGHAEI et al. | Crystal structure of Gua4 [Cu2 (Cit) 2]{Gua= Guanidinium, Cit= Citrate= 2-hydroxo-1, 2, 3-tricarboxylatopropane} | |
| Mohamadou et al. | Synthesis, crystal structure, hydrogen bonding and spectroscopy of transition-metal complexes with the ligand (N, N′-bis (2-pyridylmethyl)-1, 3-propanediamine) | |
| Radecka-Paryzek et al. | The preparation, spectral and X-ray crystallographic characterization of 2, 6-diacetylpyridinedihydrazone complex with lead (II) nitrate | |
| Lumme et al. | The structure of diamminediaquabis (uracilato) nickel (II) | |
| Kudayarova et al. | Synthesis and structure of 3, 5-diamino-1, 2, 4-triazolium tetrachloro-gallate | |
| Avdeeva et al. | New positional isomer of the [Ag2 (Ph3P) 4B10H10] complex: Coordination of the closo-decaborate anion through the 1–2 and 5–8 (3–7) edges | |
| Gavrish et al. | Syntheses, solid state and solution structures of the palladium (ii) complexes of malonamide-derived open-chain and macrocyclic ligands | |
| Yeşilel et al. | Novel silver (I)–saccharinate complexes exhibiting Ag··· π and C–H··· Ag close interactions with a new coordination mode of saccharinate | |
| Bilge et al. | Complexes of Ni (II) and Pd (II) ions with 15-and 17-membered macrocycles containing O2N2-and O2N3-donors and the crystal structures of Ni (II) and Pd (II) complexes of 2, 5-dioxa-13, 16, 19-triazatricyclo [19.4. 0.06, 11]-pentacosa-6, 8, 10, 21, 23, 25 (1)-hexaene | |
| MD4581C1 (ru) | Соединение нитрат 2-{[(проп-2-ен-1-илкарбамотиоил)гидразино]метил}пиридиния обладающее свойствами ингибитора пролиферации клеток HL-60 миелоидной лейкемии человека |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |